- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03010150
Blodprøver og spørreskjemaer for å studere overholdelse av forebyggende svelgeøvelser hos deltakere med metastaserende hode- og nakkekreft
Modellering av overholdelse av forebyggende svelgeøvelser ved hode- og nakkekreft
This trial uses blood tests and questionnaires to study how well participants with head and neck cancer that has spread to other places in the body adhere to swallowing exercises to prevent future disease. Using blood tests to study cytokines (proteins related to the immune system) may help doctors learn if certain levels of cytokines affect whether or not side effects occur and if they put participants at risk for future disease. Questionnaires may help doctors learn about the reasons head and neck cancer participants may or may not follow the swallowing exercises that they are asked to perform after receiving radiation treatments.
Studieoversikt
Status
Forhold
- Klinisk stadium III HPV-mediert (p16-positiv) orofaryngealt karsinom AJCC v8
- Stadium III Hypofarynx karsinom AJCC v8
- Stage III Laryngeal Cancer AJCC v8
- Stadium III Orofaryngeal (p16-negativ) karsinom AJCC v8
- Stadium IV Hypofaryngealt karsinom AJCC v8
- Stage IV Laryngeal Cancer AJCC v8
- Stage IV Orofaryngeal (p16-negativ) karsinom AJCC v8
- Klinisk stadium I HPV-mediert (p16-positiv) orofaryngealt karsinom AJCC v8
- Klinisk stadium II HPV-mediert (p16-positiv) orofaryngeal karsinom AJCC v8
- Patologisk stadium I HPV-mediert (p16-positiv) orofaryngealt karsinom AJCC v8
- Patologisk stadium II HPV-mediert (p16-positiv) orofaryngealt karsinom AJCC v8
- Stage IV nasofaryngealt karsinom AJCC v8
- Patologisk stadium III HPV-mediert (p16-positiv) orofaryngealt karsinom AJCC v8
- Stage IVA Nasofaryngealt karsinom AJCC v8
- Stage IVB Nasofaryngealt karsinom AJCC v8
- Stage IVA Hypofarynx karsinom AJCC v8
- Stage IVA Laryngeal Cancer AJCC v8
- Stage IVA Orofaryngeal (p16-negativ) karsinom AJCC v8
- Stadium IVB Hypofarynx karsinom AJCC v8
- Stage IVB Laryngeal Cancer AJCC v8
- Stadium IVB Orofaryngeal (p16-negativ) karsinom AJCC v8
- Metastatisk hode- og nakkekarsinom
- Karsinom av ukjent primær
- Metastatisk malign neoplasma i livmorhalsen
- Stadium I Hypofarynx karsinom AJCC v8
- Stage I nasofaryngealt karsinom AJCC v8
- Stadium II Hypofarynx karsinom AJCC v8
- Stage II Laryngeal Cancer AJCC v8
- Stage II nasofaryngealt karsinom AJCC v8
- Stadium II Orofaryngeal (p16-negativ) karsinom AJCC v8
- Stage III nasofaryngealt karsinom AJCC v8
Intervensjon / Behandling
Detaljert beskrivelse
PRIMARY OBJECTIVES:
I. To determine whether illness perceptions significantly predict adherence to swallowing exercises at 6 months after the end of radiation.
II. To determine whether sickness behaviors (depression, fatigue, pain)'s effect on illness perceptions are mediated by pro-inflammatory cytokines.
III. To determine whether social support moderates the impact of coping on appraisal of coping.
SECONDARY OBJECTIVES:
I. As a secondary aim, to determine the feasibility and utility of cardiac impedance pre-ejection period measurement as a corollary measure for depression and distress.
II. As a secondary aim, to identify potential genetic markers for swallowing dysfunction which has developed by the 6-month follow-up.
OUTLINE:
Participants provide blood samples prior to and at the 6-month visit after receiving radiation therapy. Participants also complete questionnaires either at home, in clinic, or via internet over 30 minutes prior to receiving radiation therapy and within 14 days of blood sample collection.
After completion of study, participants are followed up periodically for up to 2 years.
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiesteder
-
-
Texas
-
Houston, Texas, Forente stater, 77030
- Rekruttering
- M D Anderson Cancer Center
-
Ta kontakt med:
- Eileen H. Shinn
- Telefonnummer: 713-745-0870
-
Hovedetterforsker:
- Eileen H. Shinn
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Participants with head and neck cancer
Beskrivelse
Inclusion Criteria:
- Are dispositioned to receive radiation with curative intent for nasopharyngeal, oropharyngeal, hypopharyngeal, laryngeal, or an unknown primary cancer with cervical metastases
- Are stage II-IVb for non- human papillomavirus (HPV)- related oropharyngeal cancer
- Have HPV- related oropharynx cancer that is T1, have nodal involvement with no distant metastasis or have HPV- related oropharynx cancer that is at least T2 with no distant metastasis
- Are stage II-IVb for laryngeal cancer
- Are stage I-IVb for hypopharyngeal
- Are stage I-IVb for nasopharyngeal cancer
- Have stage I-III unknown primary cancer with cervical
Exclusion Criteria:
- Have other cancer diagnoses, except non-melanoma skin cancer
- Had treatment for previous head and neck cancer or radiation to the head and neck
- Have a history of previous head and neck surgery (excluding biopsy and/or tonsillectomy and/or tracheotomy)
- Have a current oropharyngeal dysphagia unrelated to cancer diagnosis (e.g., dysphagia due to underlying neurogenic disorder)
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
|---|---|
|
Observational (blood tests, questionnaires)
Participants provide blood samples prior to and at the 6-month visit after receiving radiation therapy. Participants also complete questionnaires either at home, in clinic, or via internet over 30 minutes prior to receiving radiation therapy and within 14 days of blood sample collection. |
Ancillary studies Provide blood samples |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Adherence to swallowing exercises
Tidsramme: Up to 6 months
|
The primary analytic approach is to use linear mixed models to determine whether illness perceptions significantly predict adherence 6 months. The study will estimate and test the illness perception subscale scores' relationship to adherence using a linear mixed model. In the model, the dependent variable is the patient's self-reported adherence score and independent variables include illness perception, follow-up assessment time point and other covariates such as demographic and medical variables, depression, pain, fatigue, emotional coping, objective coping, appraisal of coping, stress, and lack of social well-being. |
Up to 6 months
|
|
Illness perceptions
Tidsramme: Up to 6 months
|
The study's statistical tool is mediation analysis: the independent variables are the sickness behaviors (depression, fatigue, pain); the mediators are the cytokine levels, and the outcome variable is illness perception. The study will test the mediator effects based on the product of coefficients method, rather than the classical Baron & Kenny causal steps tests, since the former approach has better statistical power. The study will conduct both single-mediator analysis for each of the mediators, and multiple-mediator analysis with all mediators in the mediating process |
Up to 6 months
|
|
Effect of social support on coping
Tidsramme: Up to 6 months
|
The moderating effect of social support on coping and appraisal of coping is the statistical equivalent of testing the two-way interaction between these variables and the social support variable. Multivariate linear regression will be used, in which the dependent variable is appraisal of coping at 6 months follow-up, and independent variables include the emotion-focused coping and action-focused sub scales, social support, and their two-way interactions. In the regression, the study will control for baseline variables. In addition, we will also apply the linear mixed model to investigate the moderating effect of these variables longitudinally. The mixed model naturally accounts for the correlation of repeated measures at baseline and 6 months follow-up. |
Up to 6 months
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Eileen H Shinn, M.D. Anderson Cancer Center
Publikasjoner og nyttige lenker
Hjelpsomme linker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Antatt)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
- Stomatognatiske sykdommer
- Patologiske prosesser
- Neoplasmer etter nettsted
- Neoplasmer
- Sykdommer i luftveiene
- Neoplasmer etter histologisk type
- Neoplasmer i hode og nakke
- Neoplasmer, kjertel og epitel
- Neoplasmer i luftveiene
- Neoplastiske prosesser
- Otorhinolaryngologiske sykdommer
- Faryngeale neoplasmer
- Otorhinolaryngologiske neoplasmer
- Nasofaryngeale sykdommer
- Faryngeale sykdommer
- Laryngeale sykdommer
- Neoplasma Metastase
- Nasofaryngeale neoplasmer
- Patologiske tilstander, tegn og symptomer
- Nasofaryngealt karsinom
- Karsinom
- Laryngeale neoplasmer
- Orofaryngeale neoplasmer
- Neoplasmer, ukjent primær
- Hypofaryngeale neoplasmer
Andre studie-ID-numre
- 2016-0597
- 2016-0597 (Annen identifikator: M D Anderson Cancer Center)
- NCI-2018-01260 (Registeridentifikator: CTRP (Clinical Trial Reporting Program))
- R21DE019954 (U.S. NIH-stipend/kontrakt)
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .